Literature DB >> 26167849

Fighting an old disease with modern tools: characteristics and molecular detection methods of drug-resistant Mycobacterium tuberculosis.

Anna Engström1.   

Abstract

Tuberculosis (TB) is an ancient disease, but not a disease of the past. The increasing prevalence of drug-resistant strains of Mycobacterium tuberculosis, the causative agent of TB, demands new measures to combat the situation. Rapid and accurate detection of the pathogen, and its drug susceptibility pattern, is essential for timely initiation of treatment, and ultimately, control of the disease. Molecular-based methods offer a great chance to improve detection of drug-resistant TB; however, their development and usage should be accompanied with a profound understanding of drug resistance mechanisms and circulating M. tuberculosis strains in specific settings, as otherwise, the usefulness of such tests may be limited. This review gives an overview of the history of TB treatment and drug resistance, drug resistance mechanisms for the most commonly used drugs and molecular methods designed to detect drug-resistant strains.

Entities:  

Keywords:  MDR-TB; XDR-TB; drug resistance; infection control; next-generation; sequencing

Mesh:

Substances:

Year:  2015        PMID: 26167849     DOI: 10.3109/23744235.2015.1061205

Source DB:  PubMed          Journal:  Infect Dis (Lond)        ISSN: 2374-4243


  5 in total

1.  Small-Molecule Inhibitors Targeting Topoisomerase I as Novel Antituberculosis Agents.

Authors:  Shayna Sandhaus; Thirunavukkarasu Annamalai; Greg Welmaker; Richard A Houghten; Carlos Paz; Pamela K Garcia; Angelo Andres; Gagandeep Narula; Carolina Rodrigues Felix; Sandra Geden; Mandy Netherton; Rashmi Gupta; Kyle H Rohde; Marc A Giulianotti; Yuk-Ching Tse-Dinh
Journal:  Antimicrob Agents Chemother       Date:  2016-06-20       Impact factor: 5.191

2.  Discovery of novel bacterial topoisomerase I inhibitors by use of in silico docking and in vitro assays.

Authors:  Shayna Sandhaus; Prem P Chapagain; Yuk-Ching Tse-Dinh
Journal:  Sci Rep       Date:  2018-01-23       Impact factor: 4.379

3.  Octahedral ruthenium (II) polypyridyl complexes as antimicrobial agents against mycobacterium.

Authors:  Guojian Liao; Zhengyuan Ye; Yunlu Liu; Bin Fu; Chen Fu
Journal:  PeerJ       Date:  2017-04-27       Impact factor: 2.984

4.  Whole-Genome Sequencing for Drug Resistance Profile Prediction in Mycobacterium tuberculosis.

Authors:  Sebastian M Gygli; Peter M Keller; Matthias Egger; Sebastien Gagneux; Erik C Böttger; Marie Ballif; Nicolas Blöchliger; Rico Hömke; Miriam Reinhard; Chloé Loiseau; Claudia Ritter; Peter Sander; Sonia Borrell; Jimena Collantes Loo; Anchalee Avihingsanon; Joachim Gnokoro; Marcel Yotebieng
Journal:  Antimicrob Agents Chemother       Date:  2019-03-27       Impact factor: 5.191

Review 5.  Molecular Diagnosis of Tuberculosis.

Authors:  Fariz Nurwidya; Diah Handayani; Erlina Burhan; Faisal Yunus
Journal:  Chonnam Med J       Date:  2018-01-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.